Clinical Trials · NCT07255209
A Study of IBI362 in Chinese Adolescents With Obesity or Overweight
- Phase
- Phase 3
- Recruitment status
- Recruiting
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Enrollment
- 180
- Start date
- Dec 2025
- Locations
- 1 site, China
- Primary endpoint
- Percent Change from Baseline in BMI